Search research articles
Contact Us
Filters
Showing results (801-810 of 834) with videos related to
Page
of 84
Sort By:
Contemporary Clinical Trials
|
January 19, 2026
Expanding access to cancer genetic care for cancer survivors: Rationale and design for a randomized controlled trial of a chatbot-based genetic education and testing
Jinghua An, Maisha Huq, Erin Speiser, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
A "Four Core Genotypes" rat model to distinguish mechanisms underlying sex-biased phenotypes and diseases
Arthur P Arnold, Xuqi Chen, Michael N Grzybowski, et al.
Gynecologic Oncology
|
November 1, 2025
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer
Sara Moufarrij, Claire F Friedman, Samuel Freeman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the science
Rachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
JCO Precision Oncology
|
September 14, 2020
<i>BRCA</i> Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer
Ying L Liu, Pier Selenica, Qin Zhou, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
Dmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Gynecologic Oncology
|
January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
Ying L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 7, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer
Rachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen, et al.
Gynecologic Oncology
|
April 25, 2025
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics
Kari L Ring, Anne M Mills, Brooke E Howitt, et al.
Page
of 84
Search research articles
Search
Showing results (801-810 of 834) with videos related to
Sort By:
Page
of 84
Contemporary Clinical Trials
|
January 19, 2026
Expanding access to cancer genetic care for cancer survivors: Rationale and design for a randomized controlled trial of a chatbot-based genetic education and testing
Jinghua An, Maisha Huq, Erin Speiser, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
A "Four Core Genotypes" rat model to distinguish mechanisms underlying sex-biased phenotypes and diseases
Arthur P Arnold, Xuqi Chen, Michael N Grzybowski, et al.
Gynecologic Oncology
|
November 1, 2025
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer
Sara Moufarrij, Claire F Friedman, Samuel Freeman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the science
Rachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
JCO Precision Oncology
|
September 14, 2020
<i>BRCA</i> Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer
Ying L Liu, Pier Selenica, Qin Zhou, et al.
Journal for Immunotherapy of Cancer
|
June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
Dmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Gynecologic Oncology
|
January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
Ying L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 7, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer
Rachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen, et al.
Gynecologic Oncology
|
April 25, 2025
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics
Kari L Ring, Anne M Mills, Brooke E Howitt, et al.
Page
of 84